In an effort to mitigate the HIV virus, Johnson & Johnson has a HIV vaccine candidate that was deemed promising. Unfortunately this week the company announced that the candidate failed to provide sufficient protection against infection. J&J said its Imbokodo study posed no safety concerns, but will not continue. The study enrolled approximately 2,600 young … Continue reading “Johnson & Johnson HIV Vaccine Fails Trial”
